-
Omada shares open at $23 in Nasdaq debut after firm’s IPO
Omada Health shares rose 21% in their Nasdaq debut Friday after the virtual chronic care company priced its stock at $19 per share in its IPO. The stock opened at $23 and closed at that same level, reaching a high of $28.40 in the middle of the day. The company said in a press release…
-
AstraZeneca, Pfizer, Gilead launch most cancers drug information
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New…
-
Omada Well being goals to IPO with market cap of as much as $1.1 billion
Omada Health smart devices in use. Courtesy: Omada Health Omada Health plans to raise up to $158 million in its up coming IPO, attaining a market cap of about $1.1 billion at the top end of its expected range, according to a filing on Thursday. The virtual chronic care company filed its prospectus earlier this…
-
UnitedHealthcare faces backlash and inventory value decline
Flags fly at half staff outside the United Healthcare corporate headquarters in Minnetonka, Minnesota, Dec. 4, 2024. Stephen Maturen | Getty Images News | Getty Images It took six months, countless hours on hold and intervention from state regulators before Sue Cover says she finally resolved an over $1,000 billing dispute with UnitedHealthcare in 2023.…
-
Hinge Well being costs IPO at $32, the highest finish of anticipated vary
Hinge Health’s TrueMotion feature. Courtesy: Hinge Health Hinge Health priced its IPO at $32 per share on Wednesday, at the top end of the expected range. The digital physical therapy startup sold 8.52 million shares in the offering, raising about $273 million. The total offering was for 13.7 million shares, with the balance being sold…
-
UnitedHealth Group shares plunge on report of DOJ investigation
Bloomberg | Bloomberg | Getty Images Shares of UnitedHealth Group plunged more than 13% on Thursday following a report that the Department of Justice is conducting a criminal investigation into the health-care giant over possible Medicare fraud. The DOJ is focusing on the company’s Medicare Advantage business practices, but the exact nature of the potential…
-
Walgreens doubles down on robots to fill prescriptions amid turnaround
A robotic arm fills prescriptions at a Walgreens’ micro-fulfillment center. Courtesy: Walgreens As struggling drugstore chains work to regain their footing, Walgreens is doubling down on automation. The company is expanding the number of retail stores served by its micro-fulfillment centers, which use robots to fill thousands of prescriptions for patients who take medications to…
-
Hinge Well being unlikely path to IPO
Hinge Health co-founders Gabriel Mecklenburg (left) and Daniel Perez (right). Courtesy of Hinge Health At digital physical therapy startup Hinge Health, CEO Daniel Perez used to recognize hard-working employees with the “Cockroach Award,” a distinction that brought with it a “cockroach squad” t-shirt and a cash payout. References to the insect were abundant at the…
-
CVS Well being (CVS) earnings Q1 2025
CVS Pharmacy logo is seen in Washington DC, United States on July 9, 2024. Jakub Porzycki | Nurphoto | Getty Images CVS Health on Thursday reported first-quarter earnings and revenue that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. Shares of CVS closed 4% higher Thursday.…
-
Novo Nordisk authorized win bars many compounded Wegovy, Ozempic medication
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk scored a huge legal victory that…
